Humanized anti-human osteopontin antibody
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 5, 2010
Grant Date -
Feb 26, 2009
app pub date -
May 30, 2007
filing date -
May 31, 2006
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides a humanized anti-human osteopontin antibody having better activities (antigen binding activity, leukocyte migration inhibitory activity and the like) and/or stability (resistance to heat, low-pH conditions, denaturants and the like) than those of conventional anti-human osteopontin antibodies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully